228 related articles for article (PubMed ID: 6085827)
1. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
[No Abstract] [Full Text] [Related]
2. [Behavior and meaning of beta-thromboglobulin in chronic obliterative arteriopathy of the lower extremities. Preliminary study].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6204655
[No Abstract] [Full Text] [Related]
3. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
4. [Evaluation of the platelet component in chronic obliterating vascular disease of the lower limbs].
Avellone G; Nova S; Gullotti D; Mandalà V
Boll Soc Ital Cardiol; 1979; 24(2):135-41. PubMed ID: 548089
[No Abstract] [Full Text] [Related]
5. The beta-thromboglobulin test.
Franchi F; Caniani MT; Mannucci PM
Thromb Haemost; 1980 Oct; 44(2):107. PubMed ID: 6161422
[No Abstract] [Full Text] [Related]
6. Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Davì G; Pinto A; Francavilla G; Paterna S; Campisi D; Strano A
Thromb Res; 1985 Oct; 40(2):275-81. PubMed ID: 2933846
[No Abstract] [Full Text] [Related]
7. [Fundamental studies of a beta-thromboglobulin RIA kit].
Kanamori I; Yabashi T; Matsuo S; Higuchi C; Baba K; Nakano S; Minakuchi K; Nomura K
Radioisotopes; 1983 Dec; 32(12):641-4. PubMed ID: 6203142
[No Abstract] [Full Text] [Related]
8. Plasma beta-thromboglobulin levels and claudication degrees in patients with peripheral vascular disease.
Catalano M; Russo U; Libretti A
Angiology; 1986 May; 37(5):339-42. PubMed ID: 2424348
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin].
Russo R; Prandoni P; Pengo V; Boschello M; Compostella L; Schivazappa L
Minerva Cardioangiol; 1984 Jun; 32(6):387-91. PubMed ID: 6206442
[No Abstract] [Full Text] [Related]
10. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
Endo Y; Mamiya S; Satoh M
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):118-23. PubMed ID: 6171982
[No Abstract] [Full Text] [Related]
11. [Determination of the level of plasma beta-thromboglobulin in diabetes].
Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting plasma beta-thromboglobulin in diabetes mellitus.
Rasi V; Ikkala E; Hekali R; Myllylä G
Med Biol; 1980 Oct; 58(5):269-72. PubMed ID: 6163046
[TBL] [Abstract][Full Text] [Related]
13. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
[No Abstract] [Full Text] [Related]
14. A coated-tube radioimmunoassay for beta-thromboglobulin.
Kuronen B; Kauppinen HL; Rasi V; Kekomäki R; Myllylä G
Med Biol; 1980 Oct; 58(5):264-8. PubMed ID: 6163045
[TBL] [Abstract][Full Text] [Related]
15. Does arterial rather than venous plasma beta-thromboglobulin better reflect in vivo platelet release reaction?
Lande K; Gjesdal K; Os I; Kjeldsen SE; Eide I; Westheim A; Hjermann I
Thromb Haemost; 1985 Aug; 54(2):547. PubMed ID: 2417355
[No Abstract] [Full Text] [Related]
16. [Changes in platelet function and their correlation with the blood lipid picture in diabetic vasculopathies].
Ferri GM; Leri O; Emiliozzi P; Lucisano V; De Marco A; Amoroso A
Recenti Prog Med; 1986 May; 77(5):233-6. PubMed ID: 2426744
[No Abstract] [Full Text] [Related]
17. [Platelet aggregation in obliterating arteriopathies of the lower limbs. Preliminary findings].
Rossi M; Evangelisti L; Giusti C; Santoro G; Pentimone F; Camici M
Minerva Cardioangiol; 1982 Jun; 30(6):329-33. PubMed ID: 7133421
[No Abstract] [Full Text] [Related]
18. [Beta-thromboglobulin--an indicator of thrombocyte activation in vivo].
Parízek M; Kubisz P; Holan J
Bratisl Lek Listy; 1985 Aug; 84(2):150-6. PubMed ID: 2411363
[No Abstract] [Full Text] [Related]
19. [Significance of the determination of beta-thromboglobulin. Experience with coronary sclerosis, and diabetes].
Udvardy M; Pfliegler G; Misz M; Boda Z; Rák K
Orv Hetil; 1983 Jul; 124(30):1797-800. PubMed ID: 6194493
[No Abstract] [Full Text] [Related]
20. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
